share_log
Breakings ·  Sep 3 20:03
Rigel Pharmaceuticals- to Get Product Transfer Price Payments in Mid-20 to Lower-30% Range Based on Tiered Net Sales for Exclusive Supply of Rezlidhia
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment